Sitagliptin Diamide impurity - Request Quote
Sitagliptin Diamide impurity
| SZ CAT No: | SZ-S009039 |
| CAS No | NA |
| Mol.F. | C20H19F6N5O3 |
| Mol.Wt. | 491.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sitagliptin Diamide impurity is chemically (S)-N-Acetyl-N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)acetamide. Sitagliptin Diamide impurity is supplied with detailed characterization data compliant with regulatory guideline. Sitagliptin Diamide impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sitagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Sitagliptin Diamide impurity
Purchase Sitagliptin Diamide impurity
Sitagliptin Diamide impurity suppliers
Sitagliptin Diamide impurity manufacturers
Sitagliptin Diamide impurity price
Order Sitagliptin Diamide impurity
Enquire Sitagliptin Diamide impurity
Sitagliptin Diamide impurity cost
Sitagliptin Diamide impurity Supplier
Sitagliptin Diamide impurity Distributor
Sitagliptin Diamide impurity for Method Validation
Sitagliptin Reference Standard
Sitagliptin Diamide impurity for ANDA Filing
Sitagliptin Diamide impurity for Forced Degradation Studies
Sitagliptin Diamide impurity Identification Standards
Sitagliptin Diamide impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


